109 related articles for article (PubMed ID: 11398808)
1. Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells.
Hata A; Zerboni L; Sommer M; Kaspar AA; Clayberger C; Krensky AM; Arvin AM
Viral Immunol; 2001; 14(2):125-33. PubMed ID: 11398808
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Properties of an Immunomodulator - 15 kDa Human Granulysin.
Wei HM; Lin LC; Wang CF; Lee YJ; Chen YT; Liao YD
PLoS One; 2016; 11(6):e0156321. PubMed ID: 27276051
[TBL] [Abstract][Full Text] [Related]
3. [Granulysin: antimicrobial molecule of innate and acquired immunity in human tuberculosis].
Wargnier A; Sasportes M; Lagrange PH
Pathol Biol (Paris); 2005; 53(8-9):516-21. PubMed ID: 16081226
[TBL] [Abstract][Full Text] [Related]
4. Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells.
Krensky AM
Biochem Pharmacol; 2000 Feb; 59(4):317-20. PubMed ID: 10644038
[TBL] [Abstract][Full Text] [Related]
5. Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin.
Li Q; Dong C; Deng A; Katsumata M; Nakadai A; Kawada T; Okada S; Clayberger C; Krensky AM
Antimicrob Agents Chemother; 2005 Jan; 49(1):388-97. PubMed ID: 15616319
[TBL] [Abstract][Full Text] [Related]
6. Granulysin: a novel antimicrobial.
Kumar J; Okada S; Clayberger C; Krensky AM
Expert Opin Investig Drugs; 2001 Feb; 10(2):321-9. PubMed ID: 11178344
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus.
Primache V; Binda S; De Benedittis G; Barbi M
New Microbiol; 1998 Oct; 21(4):397-401. PubMed ID: 9812322
[TBL] [Abstract][Full Text] [Related]
8. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
[TBL] [Abstract][Full Text] [Related]
10. Granulysin induces cell death with nuclear accumulation.
Takamori Y; Ogawa K; Nagata K; Takano S; Nakamura M
J Med Dent Sci; 2005 Mar; 52(1):1-7. PubMed ID: 15868735
[TBL] [Abstract][Full Text] [Related]
11. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.
Wang Z; Choice E; Kaspar A; Hanson D; Okada S; Lyu SC; Krensky AM; Clayberger C
J Immunol; 2000 Aug; 165(3):1486-90. PubMed ID: 10903754
[TBL] [Abstract][Full Text] [Related]
13. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
Milikan JC; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibition of varicella-zoster virus replication in vitro.
Docherty JJ; Sweet TJ; Bailey E; Faith SA; Booth T
Antiviral Res; 2006 Dec; 72(3):171-7. PubMed ID: 16899306
[TBL] [Abstract][Full Text] [Related]
16. Anti-varicella-zoster virus activity of cephalotaxine esters in vitro.
Kim JE; Song YJ
J Microbiol; 2019 Jan; 57(1):74-79. PubMed ID: 30456755
[TBL] [Abstract][Full Text] [Related]
17. T-cell release of granulysin contributes to host defense in leprosy.
Ochoa MT; Stenger S; Sieling PA; Thoma-Uszynski S; Sabet S; Cho S; Krensky AM; Rollinghoff M; Nunes Sarno E; Burdick AE; Rea TH; Modlin RL
Nat Med; 2001 Feb; 7(2):174-9. PubMed ID: 11175847
[TBL] [Abstract][Full Text] [Related]
18. Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.
Miller RL; Iltis JP; Rapp F
IARC Sci Publ (1971); 1978; (24 Pt 2):991-7. PubMed ID: 221418
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia.
Molvarec A; Shiozaki A; Ito M; Toldi G; Stenczer B; Szarka A; Nakashima A; Vásárhelyi B; Rigó J; Saito S
J Reprod Immunol; 2011 Sep; 91(1-2):56-63. PubMed ID: 21763002
[TBL] [Abstract][Full Text] [Related]
20. Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes.
Latinovic-Golic S; Walch M; Sundstrom H; Dumrese C; Groscurth P; Ziegler U
BMC Immunol; 2007 Jun; 8():9. PubMed ID: 17596262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
